−3.22USD
−221.863MUSD
81.819M
About Rocket Pharmaceuticals, Inc.
Sector
Industry
CEO
Gaurav D. Shah
Website
Headquarters
Cranbury
Employees (FY)
240
Founded
1999
ISIN
US77313F1066
Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the development of gene therapy treatment options for rare and devastating pediatric diseases. Its multi-platform development approach applies the lentiviral vector and adeno-associated viral vector gene therapy platforms. Its clinical program is an LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a difficult to treat genetic disease that leads to bone marrow failure and potentially cancer. The company was founded on July 7, 1999 and is headquartered in Cranbury, NJ.
Possible Bear flagConsidering the prevailing channel, a possible short rally is imminent, which will be followed by an additional decline in price. Scalpers can enter three cents above today high for few days of rally and exit at any sign of a pullback.
A short would be appropriate at the top of the bear flag for on
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
